NEW YORK (GenomeWeb News) – GeneGo has won a $336,000 grant from the National Institute of General Medical Sciences, which it plans to use to create new types of signatures for drug resistance, the company said today.

GeneGo will use the Phase I Small Business Innovation Research grant in a collaboration with the Van Andel Institute for Translational Medicine that will focus on using GeneGo’s database and algorithms to identify key proteins in signaling networks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.